Pfizer Newsroom

Pfizer's Stock Outlook: Analysts Weigh In on Future Prospects

TipRanksApr 26 11:10 ET

Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX), Pfizer (PFE) and Madrigal Pharmaceuticals (MDGL)

TipRanksApr 25 04:15 ET

Cantor Fitzgerald Maintains Pfizer(PFE.US) With Hold Rating, Cuts Target Price to $24

Moomoo NewsApr 22 18:32 ET

TD Cowen Maintains Pfizer(PFE.US) With Hold Rating, Cuts Target Price to $28

Moomoo NewsApr 22 18:31 ET

Pfizer Analyst Ratings

BenzingaApr 22 07:48 ET

Bernstein Maintains Pfizer(PFE.US) With Hold Rating, Maintains Target Price $30

Moomoo NewsApr 22 06:31 ET

BofA Securities Maintains Pfizer(PFE.US) With Hold Rating, Cuts Target Price to $26

Moomoo NewsApr 21 07:32 ET

BMO Capital Maintains Pfizer(PFE.US) With Buy Rating, Cuts Target Price to $30

Moomoo NewsApr 17 19:33 ET

Leerink Partners Maintains Pfizer(PFE.US) With Hold Rating, Maintains Target Price $28

Moomoo NewsApr 16 07:31 ET

A Quick Look at Today's Ratings for Pfizer(PFE.US), With a Forecast Between $23 to $32

Moomoo NewsApr 15 09:00 ET

TD Cowen Remains a Hold on Pfizer (PFE)

TipRanksApr 15 07:52 ET

Pfizer's Undervalued Potential: Strong Buy Rating Amid Strategic Growth and Resilience

TipRanksApr 15 07:32 ET

Citi Reaffirms Their Hold Rating on Pfizer (PFE)

TipRanksApr 15 06:45 ET

Viking Therapeutics' VK2735 Gains Buy Rating Amid Pfizer's GLP-1 Drug Halt and Promising Trial Results

TipRanksApr 15 06:24 ET

Pfizer's Hold Rating: Balancing Danuglipron Discontinuation With Long-term Growth Prospects

TipRanksApr 15 05:58 ET

Pfizer (PFE) Gets a Buy From Jefferies

TipRanksApr 14 14:15 ET

UBS Reaffirms Their Hold Rating on Pfizer (PFE)

TipRanksApr 14 12:32 ET

Pfizer (PFE) Gets a Hold From J.P. Morgan

TipRanksApr 14 09:41 ET

Pfizer's Danuglipron Discontinuation: Limited Impact on Stock Despite Hold Rating

TipRanksApr 14 09:01 ET

Affirm, Grab, Viking, Pfizer, Eli Lilly: Trending by Analysts

TipRanksApr 12 05:07 ET